UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 745

Sortiert nach

Association of Carpal Tunnel Syndrome With Amyloidosis, Heart Failure, and Adverse Cardiovascular Outcomes

Journal of the American College of Cardiology, 2019-07, Vol.74 (1), p.15-23

2019

Volltextzugriff (PDF)

Pooled analysis of Phase III trials indicate contrasting influences of renal function on blood pressure, body weight, and HbA1c reductions with empagliflozin

Kidney international, 2018-01, Vol.93 (1), p.231-244

2018

Volltextzugriff (PDF)

Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus

Cochrane database of systematic reviews, 2013-11 (11), p.CD008143-CD008143

2013

Volltextzugriff (PDF)

Oral Anticoagulation and Antiplatelets in Atrial Fibrillation Patients After Myocardial Infarction and Coronary Intervention

Journal of the American College of Cardiology, 2013-09, Vol.62 (11), p.981-989

2013

Volltextzugriff (PDF)

Exploring transitions towards sustainable farming practices through participatory research – The case of Danish farmers' use of species mixtures

Agricultural systems, 2021-04, Vol.189, p.103053, Article 103053

2021

Volltextzugriff (PDF)

The effect of sodium glucose cotransporter 2 inhibition with empagliflozin on microalbuminuria and macroalbuminuria in patients with type 2 diabetes

Diabetologia, 2016-09, Vol.59 (9), p.1860-1870

2016

Volltextzugriff (PDF)

Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials

BMJ (Online), 2011-11, Vol.343 (7834), p.d6898

International edition, 2011

Volltextzugriff (PDF)

Virtual hype meets reality: Users’ perception of immersive journalism

Journalism (London, England), 2021-10, Vol.22 (10), p.2637-2653

2021

Volltextzugriff (PDF)

Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus

Cochrane database of systematic reviews, 2011-06 (6), p.CD008143

2011

Volltextzugriff (PDF)

Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus

Cochrane database of systematic reviews, 2015-07, Vol.2015 (7)

2015

Volltextzugriff (PDF)

Effect of empagliflozin monotherapy on postprandial glucose and 24-hour glucose variability in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, 4-week study

Cardiovascular diabetology, 2015-01, Vol.14 (1), p.11-11, Article 11

2015

Volltextzugriff (PDF)

Advanced heart failure: time to screen?

European journal of heart failure, 2022-09, Vol.24 (9), p.1504-1505

2022

Volltextzugriff (PDF)

The effect of empagliflozin on the total burden of cardiovascular and hospitalization events in the Asian and non‐Asian populations of the EMPA‐REG OUTCOME trial of patients with type 2 diabetes and cardiovascular disease

Diabetes, obesity & metabolism, 2022-04, Vol.24 (4), p.662-674

2022

Volltextzugriff (PDF)

Pharmacodynamic Effects of Single and Multiple Doses of Empagliflozin in Patients With Type 2 Diabetes

Clinical therapeutics, 2016-10, Vol.38 (10), p.2265-2276

2016

Volltextzugriff (PDF)

Pandemic preparedness systems and diverging COVID-19 responses within similar public health regimes: a comparative study of expert perceptions of pandemic response in Denmark, Norway, and Sweden

Globalization and health, 2022-01, Vol.18 (1), p.3-3, Article 3

2022

Volltextzugriff (PDF)

Developmental exposure to the brominated flame retardant DE-71 reduces serum thyroid hormones in rats without hypothalamic-pituitary-thyroid axis activation or neurobehavioral changes in offspring

PloS one, 2022-07, Vol.17 (7), p.e0271614-e0271614

2022

Volltextzugriff (PDF)

Disease activity in inflammatory bowel disease is associated with increased risk of myocardial infarction, stroke and cardiovascular death--a Danish nationwide cohort study

PloS one, 2013-02, Vol.8 (2), p.e56944-e56944

2013

Volltextzugriff (PDF)

Empagliflozin reduces body weight and indices of adipose distribution in patients with type 2 diabetes mellitus

Diabetes & vascular disease research, 2016-03, Vol.13 (2), p.119-126

2016

Volltextzugriff (PDF)

Diuretic treatment before and after transcatheter aortic valve implantation: A Danish nationwide study

PloS one, 2023-03, Vol.18 (3), p.e0282636-e0282636

2023

Volltextzugriff (PDF)

Linagliptin treatment is associated with altered cobalamin (VitB12) homeostasis in mice and humans

Scientific reports, 2023-01, Vol.13 (1), p.601-601, Article 601

2023

Volltextzugriff (PDF)

Patterns of unplanned readmissions after heart failure hospitalization: novel longitudinal perspectives from Australia and New Zealand

European journal of heart failure, 2021-01, Vol.23 (1), p.41-42

2021

Volltextzugriff (PDF)

Minaeans in the Mediterranean. Reevaluating two Old South Arabian inscriptions from Delos

Arabian archaeology and epigraphy, 2023-11, Vol.34 (1), p.128-132

2023

Volltextzugriff (PDF)

Potential contribution of haemoconcentration to changes in lipid variables with empagliflozin in patients with type 2 diabetes: A post hoc analysis of pooled data from four phase 3 randomized clinical trials

Diabetes, obesity & metabolism, 2021-12, Vol.23 (12), p.2763-2774

2021

Volltextzugriff (PDF)

Long-term safety and effectiveness of linagliptin by baseline body mass index in Japanese patients with type 2 diabetes: a 3-year post-marketing surveillance study

Expert opinion on drug safety, 2022-10, Vol.21 (10), p.1303-1313

2022

Volltextzugriff (PDF)

Effect of empagliflozin on total myocardial infarction events by type and additional coronary outcomes: insights from the randomized EMPA-REG OUTCOME trial

Cardiovascular diabetology, 2024-07, Vol.23 (1), p.1-7, Article 248

2024

Volltextzugriff (PDF)

1 – 25 von 745

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(668)
Mit Volltextzugriff
(646)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(527)
Life Sciences & Biomedicine
(421)
Humans
(317)
Female
(179)
Male
(174)
Middle Aged
(119)
Biological And Medical Sciences
(107)
Adult
(97)
Aged
(93)
Animals
(88)
Medical Sciences
(72)
Cardiovascular System & Cardiology
(69)
Physical Sciences
(69)
Cardiac & Cardiovascular Systems
(66)
Fundamental And Applied Biological Sciences. Psychology
(47)
Risk Factors
(47)
Biochemistry & Molecular Biology
(46)
Science & Technology - Other Topics
(46)
Patients
(45)
Diabetes
(44)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Association of Carpal Tunnel Syndrome With Amyloidosis, Heart Failure, and Adverse Cardiovascular Outcomes

Pooled analysis of Phase III trials indicate contrasting influences of renal function on blood pressure, body weight, and HbA1c reductions with empagliflozin

Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus

Oral Anticoagulation and Antiplatelets in Atrial Fibrillation Patients After Myocardial Infarction and Coronary Intervention

Exploring transitions towards sustainable farming practices through participatory research – The case of Danish farmers' use of species mixtures

The effect of sodium glucose cotransporter 2 inhibition with empagliflozin on microalbuminuria and macroalbuminuria in patients with type 2 diabetes

Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials

Virtual hype meets reality: Users’ perception of immersive journalism

Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus

Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus

Effect of empagliflozin monotherapy on postprandial glucose and 24-hour glucose variability in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, 4-week study

Advanced heart failure: time to screen?

The effect of empagliflozin on the total burden of cardiovascular and hospitalization events in the Asian and non‐Asian populations of the EMPA‐REG OUTCOME trial of patients with type 2 diabetes and cardiovascular disease

Pharmacodynamic Effects of Single and Multiple Doses of Empagliflozin in Patients With Type 2 Diabetes

Pandemic preparedness systems and diverging COVID-19 responses within similar public health regimes: a comparative study of expert perceptions of pandemic response in Denmark, Norway, and Sweden

Developmental exposure to the brominated flame retardant DE-71 reduces serum thyroid hormones in rats without hypothalamic-pituitary-thyroid axis activation or neurobehavioral changes in offspring

Disease activity in inflammatory bowel disease is associated with increased risk of myocardial infarction, stroke and cardiovascular death--a Danish nationwide cohort study

Empagliflozin reduces body weight and indices of adipose distribution in patients with type 2 diabetes mellitus

Diuretic treatment before and after transcatheter aortic valve implantation: A Danish nationwide study

Linagliptin treatment is associated with altered cobalamin (VitB12) homeostasis in mice and humans

Patterns of unplanned readmissions after heart failure hospitalization: novel longitudinal perspectives from Australia and New Zealand

Minaeans in the Mediterranean. Reevaluating two Old South Arabian inscriptions from Delos

Potential contribution of haemoconcentration to changes in lipid variables with empagliflozin in patients with type 2 diabetes: A post hoc analysis of pooled data from four phase 3 randomized clinical trials

Long-term safety and effectiveness of linagliptin by baseline body mass index in Japanese patients with type 2 diabetes: a 3-year post-marketing surveillance study

Effect of empagliflozin on total myocardial infarction events by type and additional coronary outcomes: insights from the randomized EMPA-REG OUTCOME trial

Suchergebnisse filtern